First phase I trial of DCVax-Brain in patients with glioblastoma

Trial Profile

First phase I trial of DCVax-Brain in patients with glioblastoma

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Aug 2010

At a glance

  • Drugs Dendritic cell vaccine-Northwest Biotherapeutics (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Sponsors Northwest Biotherapeutics
  • Most Recent Events

    • 03 Aug 2010 Follow-up data from pooled phase I and II trials reported in a Northwest Biotherapeutics media release.
    • 05 Nov 2009 New trial record.
    • 21 Oct 2009 Further follow-up data reported in a Northwest Biotherapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top